TRIM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.141600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.635780E-01
Normal-vs-Stage2
5.525200E-01
Normal-vs-Stage3
7.975800E-01
Normal-vs-Stage4
1.166430E-01
Stage1-vs-Stage2
8.593400E-01
Stage1-vs-Stage3
9.750200E-02
Stage1-vs-Stage4
1.747430E-01
Stage2-vs-Stage3
4.152000E-01
Stage2-vs-Stage4
1.709590E-01
Stage3-vs-Stage4
6.372000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.372400E-01
Normal-vs-AfricanAmerican
2.840800E-01
Normal-vs-Asian
4.235000E-01
Caucasian-vs-AfricanAmerican
9.452000E-01
Caucasian-vs-Asian
9.905000E-01
AfricanAmerican-vs-Asian
9.431600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.307600E-01
Normal-vs-Female
4.646000E-01
Male-vs-Female
4.565800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.432200E-01
Normal-vs-Age(41-60Yrs)
4.826600E-01
Normal-vs-Age(61-80Yrs)
4.874400E-01
Normal-vs-Age(81-100Yrs)
8.702000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.582400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.040200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.263200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.340600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.581800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.542000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.549400E-01
Normal-vs-Daily Drinker
6.337800E-01
Normal-vs-Weekly Drinker
7.059600E-01
Normal-vs-Occasional Drinker
3.669800E-02
Normal-vs-Social Drinker
3.754600E-01
Non Drinker-vs-Daily Drinker
5.274800E-01
Non Drinker-vs-Weekly Drinker
6.836200E-01
Non Drinker-vs-Occasional Drinker
4.938400E-02
Non Drinker-vs-Social Drinker
1.670210E-01
Daily Drinker-vs-Weekly Drinker
9.843600E-01
Daily Drinker-vs-Occasional Drinker
8.064400E-02
Daily Drinker-vs-Social Drinker
5.496200E-01
Weekly Drinker-vs-Occasional Drinker
9.289800E-02
Weekly Drinker-vs-Social Drinker
6.132600E-01
Occasional Drinker-vs-Social Drinker
1.331960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.810750E-01
Normal-vs-Grade 2
2.061800E-01
Normal-vs-Grade 3
9.688100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.687800E-01
Grade 1-vs-Grade 3
4.899600E-01
Grade 1-vs-Grade 4
1.810750E-01
Grade 2-vs-Grade 3
1.763570E-01
Grade 2-vs-Grade 4
2.061800E-01
Grade 3-vs-Grade 4
9.688100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.643600E-01
Normal-vs-NonDiabetic
5.056400E-01
Diabetic-vs-NonDiabetic
1.549390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.370800E-01
Normal-vs-NoPancreatitis
5.281600E-01
Pancreatitis-vs-NoPancreatitis
5.058200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.915800E-01
Normal-vs-N1
4.759600E-01
N0-vs-N1
1.631790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.793000E-01
Normal-vs-TP53-NonMutant
2.398400E-01
TP53-Mutant-vs-TP53-NonMutant
8.936400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
